Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0000950170-24-029530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-11 | 2024-03-07+ | SRPT | Brown Ryan Edward | EVP, GC | F - Tax | $122.19 | -1,405 | 28.7K | -5% | -$171.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | F | D | 506 | $120.49 | 29,587 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023. |
| 2 | Common | Common Stock | 2024-03-08 | F | D | 899 | $123.14 | 28,688 | D | — | — | (F2) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022. |